Copyright
©The Author(s) 2016.
World J Gastroenterol. Jun 14, 2016; 22(22): 5183-5192
Published online Jun 14, 2016. doi: 10.3748/wjg.v22.i22.5183
Published online Jun 14, 2016. doi: 10.3748/wjg.v22.i22.5183
Figure 3 The correlation analysis miR-106b vs miR-93, miR-106b vs miR-25, and miR-93 vs miR-25 expression in tumor regions of patients with hepatitis B virus-associated hepatocellular carcinoma (n = 108).
A: The correlation between miR-106b and miR-93 expression; B: The correlation between miR-106b and miR-25 expression; C: The correlation between miR-93 and miR-25 expression. Data represent the correlation coefficient (r). a.u.: Arbitrary unit. HCC: Hepatocellular carcinoma; HBV: Hepatitis B virus.
- Citation: Yen CS, Su ZR, Lee YP, Liu IT, Yen CJ. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma. World J Gastroenterol 2016; 22(22): 5183-5192
- URL: https://www.wjgnet.com/1007-9327/full/v22/i22/5183.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i22.5183